MRK
Merck & Company Inc
139.50$
-3.3%
vs. previous close
Closing price · As of: Oct 5, 2026
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 26.7% | 26.7% | 22.4% | 23.2% | 24.5% | 24.5% | 24.9% | 24.3% | 24.4% | 29.5% | 18.1% | 26.5% | 24.6% | |
| 73.3% | 73.3% | 77.6% | 76.8% | 75.5% | 75.5% | 75.1% | 75.7% | 75.6% | 70.5% | 81.9% | 73.5% | 75.4% | |
| 20.7% | 65.8% | 25.3% | 21.7% | 35.2% | 29.3% | 20.0% | 22.4% | 20.7% | 15.3% | 77.1% | 58.7% | 42.7% | |
| 15.8% | 2.3% | 15.7% | 17.0% | 16.4% | 1.9% | 16.3% | 16.7% | 15.3% | 17.4% | 16.6% | 17.5% | 16.7% | |
| 36.5% | 85.0% | 63.5% | 38.7% | 51.6% | 47.7% | 32.2% | 35.4% | 32.2% | 32.8% | 93.5% | 77.6% | 58.7% | |
| 36.8% | -11.7% | 36.5% | 38.0% | 23.9% | 27.8% | 43.0% | 40.2% | 43.4% | 37.7% | -11.6% | -4.1% | 16.7% | |
| 2.0% | 2.1% | 1.9% | 1.9% | 2.0% | 2.1% | 2.0% | 1.9% | 1.9% | 2.5% | 2.9% | 3.2% | 2.6% | |
| 35.2% | -14.0% | 35.9% | 37.3% | 24.6% | 26.7% | 37.8% | 31.6% | 39.3% | 21.0% | -21.7% | -4.1% | 9.0% | |
| 5.5% | -5.6% | – | 3.4% | 5.6% | 2.7% | 5.2% | 3.6% | 5.6% | 2.8% | 4.4% | 3.9% | 4.2% | |
| 29.7% | -8.4% | 30.2% | 33.9% | 19.0% | 24.0% | 32.5% | 28.0% | 33.7% | 18.2% | -26.0% | -8.0% | 4.8% | |
| 43.5% | -5.3% | 42.8% | 46.2% | 33.7% | 36.5% | 46.8% | 40.3% | 47.4% | 38.6% | -12.4% | 8.6% | 20.8% |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 5, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.